Literature DB >> 18083723

Detecting chronic kidney disease in older people; what are the implications?

Paul J Roderick1, Richard J Atkins, Liam Smeeth, Dorothea M Nitsch, Richard B Hubbard, Astrid E Fletcher, Astrid E Flectcher, Chris J Bulpitt.   

Abstract

BACKGROUND: national policy is focused on early identification, referral and management of chronic kidney disease (CKD) to prevent both progression to endstage renal failure and cardiovascular disease. However, the significance of identifying CKD in older people is unclear.
OBJECTIVE: to determine the frequency of CKD in older people using estimated glomerular filtration rate (eGFR), and its associations with morbidity and functional measures.
DESIGN: observational cross-sectional analysis of baseline data from a large cluster randomised trial of health and social assessment of older people in the community.
SETTING: included 53 general practices in Great Britain.
SUBJECTS: subjects were people aged 75 and over, living in the community participating in the trial arm where systematic blood testing was undertaken.
METHODS: the response rate for participation at baseline assessment of those eligible was 73% (15,536/20,934), of whom 13,109 (86%) participants had a serum creatinine measured, and an eGFR derivable using the Modification of Diet in Renal Disease formula (MDRD) in ml/min/1.73 m(2). Key outcomes were the prevalence of CKD stages and their associations with morbidity and functional status.
RESULTS: prevalence of CKD was 56.1% (95% CI 55.3-57.0) for eGFR < 60, 17.7% for eGFR < 45 (95% CI 17.1-18.4), and 2.7% (95% CI 2.4-2.9) for eGFR < 30. It was higher in older ages, females, and those with cardiovascular comorbidity and doctor-diagnosed hypertension but not with diabetes. The strength of the association with measures of morbidity and functional impairment increased as eGFR fell, especially once the eGFR was < 45. For example, the odds ratios in males for anaemia for an eGFR < 30, 30-44 and 45-59 versus reference GFR > 60 were 8.3 (5.1-13.7), 3.0 (2.1-4.2) and 1.2(0.8-1.7) respectively; similar figures for partial dependence on activities of daily living were 2.2 (1.4-3.3), 1.6 (1.2-2.1) and 1.0 (0.9-1.3) and for lack of physical activity 2.20 (1.39-3.48), 1.78 (1.37-2.32) and 1.10 (0.92-1.32).
CONCLUSIONS: an eGFR < 60 is very common in older people. An eGFR < 45 identifies a smaller sub-group of older people with significant comorbidity, impaired functional state and a high risk of potentially reversible consequences such as anaemia. The benefits of identifying older people with an eGFR > 45 need to be determined.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18083723     DOI: 10.1093/ageing/afm180

Source DB:  PubMed          Journal:  Age Ageing        ISSN: 0002-0729            Impact factor:   10.668


  29 in total

1.  Natural history of older adults with impaired kidney function: the InCHIANTI study.

Authors:  Sandra V Giannelli; Christophe E Graf; François R Herrmann; Jean-Pierre Michel; Kushang V Patel; Francesco Pizzarelli; Luigi Ferrucci; Jack Guralnik
Journal:  Rejuvenation Res       Date:  2011-09-28       Impact factor: 4.663

Review 2.  Aging and chronic kidney disease: the impact on physical function and cognition.

Authors:  Shuchi Anand; Kirsten L Johansen; Manjula Kurella Tamura
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-08-02       Impact factor: 6.053

3.  A Study of the Applicability of GFR Evaluation Equations for an Elderly Chinese Population.

Authors:  Q Huang; X Sun; Y Chen; M Zhang; L Tang; S Liu; R Wei; S Wang; J Zhou; X Cao; W Zhang; G Cai; X Chen
Journal:  J Nutr Health Aging       Date:  2015-06       Impact factor: 4.075

4.  Epidemiology and prognostic significance of chronic kidney disease in the elderly--the Three-City prospective cohort study.

Authors:  Benedicte Stengel; Marie Metzger; Marc Froissart; Muriel Rainfray; Claudine Berr; Christophe Tzourio; Catherine Helmer
Journal:  Nephrol Dial Transplant       Date:  2011-06-15       Impact factor: 5.992

5.  Impact of chronic kidney disease on activities of daily living in community-dwelling older adults.

Authors:  C Barrett Bowling; Patricia Sawyer; Ruth C Campbell; Ali Ahmed; Richard M Allman
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-03-31       Impact factor: 6.053

6.  Chronic kidney disease in patients with diabetes mellitus type 2 or hypertension in general practice.

Authors:  Victor van der Meer; H Petra M Wielders; Diana C Grootendorst; Joost S de Kanter; Yvo Wj Sijpkens; Willem Jj Assendelft; Jacobijn Gussekloo; Friedo W Dekker; Ymte Groeneveld
Journal:  Br J Gen Pract       Date:  2010-12       Impact factor: 5.386

7.  Disorders of lipid metabolism and chronic kidney disease in the elderly.

Authors:  Devasmita Choudhury; Meryem Tuncel; Moshe Levi
Journal:  Semin Nephrol       Date:  2009-11       Impact factor: 5.299

8.  Low documentation of chronic kidney disease among high-risk patients in a managed care population: a retrospective cohort study.

Authors:  Idris Guessous; William McClellan; Suma Vupputuri; Haimanot Wasse
Journal:  BMC Nephrol       Date:  2009-09-16       Impact factor: 2.388

9.  Association of Reduced eGFR and Albuminuria with Serious Fall Injuries among Older Adults.

Authors:  C Barrett Bowling; Samantha G Bromfield; Lisandro D Colantonio; Orlando M Gutiérrez; Daichi Shimbo; Kristi Reynolds; Nicole C Wright; Jeffrey R Curtis; Suzanne E Judd; Harold Franch; David G Warnock; William McClellan; Paul Muntner
Journal:  Clin J Am Soc Nephrol       Date:  2016-04-18       Impact factor: 8.237

10.  A randomised single-blind study to improve health-related quality of life by treating anaemia of chronic kidney disease with Aranesp® (darbepoetin alfa) in older people: STIMULATE.

Authors:  Simon D Roger; Sarbjit V Jassal; Michael C Woodward; Steven Soroka; Lawrence P McMahon
Journal:  Int Urol Nephrol       Date:  2013-08-28       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.